# REPEAT RNA THERAPEUTICS INC: Development of novel small molecules to treat myotonic dystrophy

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | REPEAT RNA THERAPEUTICS INC |
| Location | MENANDS, NY |
| Project | Development of novel small molecules to treat myotonic dystrophy |
| Project number | 1R41NS143535-01A1 |
| Mechanism | R41 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $322,177 |
| Awarded | 2026-09-10 |
| Project period | 2026-09-10 to 2028-08-31 |
| UEI | GVFHSMPEMSK8 |

## Why this score
- Award of $322,177.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11315150). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.